| Company Name: |
TOSUN PHARM
|
| Tel: |
020-61855200 13326451905 |
| Email: |
260366801@qq.com |
| Products Intro: |
Product Name:Oseltamivir Impurity 23
CAS:1191921-01-3
Purity:98%以上 Package:10mg;50mg;100mg等多种规格 Remarks:REF-O06036
|
| Company Name: |
Shaanxi Dideu Medichem Co. Ltd
|
| Tel: |
029-029-81024372 17792795018 |
| Email: |
1027@dideu.com |
| Products Intro: |
Product Name:(3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate
CAS:1191921-01-3
Purity:98% Package:25千克/桶
|
(3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate manufacturers
- Oseltamivir-acetate
-
- $48.00 / 2mg
-
2026-01-05
- CAS:1191921-01-3
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | (3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate Basic information |
| Product Name: | (3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate | | Synonyms: | (3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate;Oseltamivir-acetate;Oseltamivir Impurity456;Oseltamivir Impurity455;1-Cyclohexene-1-carboxylic acid, 4,5-bis(acetylamino)-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-;Bronopol Impurity 2 | | CAS: | 1191921-01-3 | | MF: | C18H30N2O5 | | MW: | 354.44 | | EINECS: | | | Product Categories: | | | Mol File: | 1191921-01-3.mol |  |
| | (3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate Chemical Properties |
| Boiling point | 572.2±50.0 °C(Predicted) | | density | 1.10±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | form | Solid | | pka | 14.44±0.70(Predicted) | | color | White to off-white |
| | (3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate Usage And Synthesis |
| Uses | Oseltamivir-acetate is an impurity of Oseltamivir. Oseltamivir is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B[1][2]. | | Biological Activity | Oseltamivir-acetate is an impurity of Oseltamivir. Oseltamivir is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B[1][2]. | | References | [1]. Huang H, et al. Transplacental transfer of Oseltamivir phosphate and its metabolite Oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population. J Matern Fetal Neonatal Med. 2016 Aug 8:1-5. [2]. de Oliveira JT, et al. Anti-influenza neuraminidase inhibitor Oseltamivir phosphate induces canine mammary cancer cell aggressiveness. PLoS One. 2015 Apr 7;10(4):e0121590. |
| | (3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate Preparation Products And Raw materials |
|